Literature DB >> 28776642

Diagnosis of monogenic liver diseases in childhood by next-generation sequencing.

A Stalke1,2, B Skawran2, B Auber2, T Illig2,3, B Schlegelberger2, N Junge1, I Goldschmidt1, C Leiskau1, N von Neuhoff2,4, U Baumann1, E-D Pfister1.   

Abstract

Next-generation sequencing (NGS) has opened up novel diagnostic opportunities for children with unidentified, but suspected inherited diseases. We describe our single-center experience with NGS diagnostics in standard clinical scenarios in pediatric hepatology. We investigated 135 children with suspected inherited hepatopathies, where initially no causative pathogenic variant had been identified, with an amplicon-based NGS panel of 21 genes associated with acute and chronic hepatopathies. In 23 of these patients, we detected pathogenic or likely pathogenic variants in 10 different genes. We present 6 novel variants. A total of 14 of these patients presented with the characteristic phenotype of the related hepatopathy. Nine patients showed only few or atypical clinical symptoms or presented with additional signs. In another 13 out of 135 cases, we detected variants of unknown significance (VUS) in 9 different genes. Only 2 of these patients showed characteristic phenotypes conclusive with the detected variants, whereas 11 patients showed unspecific or atypical phenotypes. Our multi-gene panel is a fast and comprehensive tool to diagnose inherited pediatric hepatopathies. We also illustrate the challenge of dealing with genetic variants and highlight arising clinical questions, especially in patients with atypical phenotypes.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  hepatopathy; monogenic liver disease; next-generation sequencing; pediatrics

Mesh:

Year:  2017        PMID: 28776642     DOI: 10.1111/cge.13120

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  5 in total

Review 1.  Paediatric genomics: diagnosing rare disease in children.

Authors:  Caroline F Wright; David R FitzPatrick; Helen V Firth
Journal:  Nat Rev Genet       Date:  2018-02-05       Impact factor: 53.242

2.  Targeted-Capture Next-Generation Sequencing in Diagnosis Approach of Pediatric Cholestasis.

Authors:  Marion Almes; Anne Spraul; Mathias Ruiz; Muriel Girard; Bertrand Roquelaure; Nolwenn Laborde; Fréderic Gottrand; Anne Turquet; Thierry Lamireau; Alain Dabadie; Marjorie Bonneton; Alice Thebaut; Babara Rohmer; Florence Lacaille; Pierre Broué; Alexandre Fabre; Karine Mention-Mulliez; Jérôme Bouligand; Emmanuel Jacquemin; Emmanuel Gonzales
Journal:  Diagnostics (Basel)       Date:  2022-05-07

3.  Alagille syndrome mutation update: Comprehensive overview of JAG1 and NOTCH2 mutation frequencies and insight into missense variant classification.

Authors:  Melissa A Gilbert; Robert C Bauer; Ramakrishnan Rajagopalan; Christopher M Grochowski; Grace Chao; Deborah McEldrew; James A Nassur; Elizabeth B Rand; Bryan L Krock; Binita M Kamath; Ian D Krantz; David A Piccoli; Kathleen M Loomes; Nancy B Spinner
Journal:  Hum Mutat       Date:  2019-08-26       Impact factor: 4.878

4.  Targeted Sequencing and RNA Assay Reveal a Noncanonical JAG1 Splicing Variant Causing Alagille Syndrome.

Authors:  Yiyao Chen; Xueli Liu; Songchang Chen; Junyu Zhang; Chenming Xu
Journal:  Front Genet       Date:  2020-01-24       Impact factor: 4.599

5.  Functional characterization of a JAG1 5'UTR variant in a patient with clinically observed Alagille syndrome.

Authors:  Nicole Buhl; Eva-Doreen Pfister; Jens Bohne; Ulrich Baumann; Björn Hartleben; Brigitte Schlegelberger; Thomas Illig; Britta Skawran; Amelie Stalke
Journal:  Clin Genet       Date:  2022-06-27       Impact factor: 4.296

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.